Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds CRPOF.
No tracked institution reports a position in CRPOF as of their last filing.
No one on the platform has traded CRPOF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CRPOFCeapro Inc. | $0.17 | -13.04% | $13M | — |
| ABDXFAbingdon Health Plc | $0.14 | -2.77% | $35M | — |
| AMHVAmerican Hemp Ventures, Inc. | $0.98 | +0.00% | $16M | — |
| EIGRQEiger BioPharmaceuticals, Inc. | $8.50 | +6.25% | $13M | — |
| LVCLYLiving Cell Technologies Limited | $0.03 | +24.39% | $11M | — |
| NOXOFNoxopharm Limited | $0.04 | +0.00% | $15M | — |
| PXXLFPoxel S.A. | $0.26 | +0.00% | $16M | — |
Source: Financial Modeling Prep · peers by sector/industry
$CRPOF alot more dissidents of deal than $AEZS when deal close?
View on StockTwits ↗
$AEZS $CRPOF Merger News Commentary -I’m still digesting. -The stock trading <2% of shares and closing flat shows the market’s low enthusiasm. -The board overlap between AEZS and CRPOF creates questions. -If I vote no, I am fairly confident shareholders can reject merger.
View on StockTwits ↗
$CRPOF Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights Article Available on StockTitan Website.
View on StockTwits ↗$CRPOF Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases Article Available on StockTitan Website.
View on StockTwits ↗
Ceapro Sees Short Interest Decrease from 5,300 shares to 1,100 shares. $CRPOF https://www.marketbeat.com/stocks/OTCMKTS/CRPOF/short-interes
View on StockTwits ↗$CRPOF Ceapro Inc. Enters into Technical Collaboration with NATEX Prozesstechnologie GmbH and Provides Update on the Scale-Up Project for its Patented Pressurized Gas eXpanded (PGX) Technology https://www.stocktitan.net/news/CRPOF/ceapro-inc-enters-into-technical-collaboration-with-natex-3bcll1mml5k2.html
View on StockTwits ↗$CRPOF Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial Results and Provides Corporate Update https://www.stocktitan.net/news/CRPOF/ceapro-inc-reports-2023-second-quarter-and-six-month-financial-40s23b0u6mmc.html
View on StockTwits ↗$CRPOF Ceapro Extends Exclusive International Supply and Distribution Agreement with Leading Global Provider of Active Ingredients, Symrise https://www.stocktitan.net/news/CRPOF/ceapro-extends-exclusive-international-supply-and-distribution-as33jsxkg65m.html
View on StockTwits ↗$CRPOF Ceapro Announces Next Phase of Research Collaboration with the Angiogenesis Foundation https://www.stocktitan.net/news/CRPOF/ceapro-announces-next-phase-of-research-collaboration-with-the-hbfz7t4vlldw.html
View on StockTwits ↗$CRPOF Ceapro to Participate in the Virtual Investor Summer Spotlight Series https://www.stocktitan.net/news/CRPOF/ceapro-to-participate-in-the-virtual-investor-summer-spotlight-u8forarq3nr1.html
View on StockTwits ↗Ceapro Sees Short Interest Increase from 4,600 shares to 18,500 shares. $CRPOF https://www.marketbeat.com/stocks/OTCMKTS/CRPOF/short-intere
View on StockTwits ↗
$CRPOF [15s. delayed]: Issued Press Release on June 07, 09:05:00: Ceapro Announces Results of 2023 Shareholders’ Meeting https://s.flashalert.me/hKQwYO
View on StockTwits ↗$CRPOF Ceapro Announces Results of 2023 Shareholders’ Meeting https://www.stocktitan.net/news/CRPOF/ceapro-announces-results-of-2023-shareholders-dsigtr36uhn6.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.